Moreover, a follow-up study is planned to further investigate the anti-cancer mechanism of TA3 in colorectal cancer in relation to whether TA3 binds directly to CNOT2 and MID1IP1 to interfere with expression. The gene discussed is CNOT2; the disease is colorectal cancer.